Axsome Therapeutics AXSM Inventory turnover
Inventory turnover at other companies
Other financials
Where this comes from
Calculated from Axsome Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's inventory turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's inventory turnover?
- Axsome Therapeutics (AXSM) reported inventory turnover of 2.2× in Q1 2026.
- How has Axsome Therapeutics's inventory turnover changed year-over-year?
- Axsome Therapeutics's inventory turnover decreased by 5.0% year-over-year, from 2.3× to 2.2×.
- What is the long-term trend for Axsome Therapeutics's inventory turnover?
- Over 2 years (2023 to 2025), Axsome Therapeutics's inventory turnover has grown at a -9.9% compound annual growth rate (CAGR), from 2.7× to 2.2×.
- What does inventory turnover mean?
- How many times a year the company sells through and restocks its inventory.
- How do you interpret inventory turnover?
- Higher turnover ties up less cash in stock and reduces obsolescence risk, but too high can signal stock-outs and lost sales. Read against peers and the company's own history.
- How does inventory turnover compare across companies?
- Only meaningful for businesses that carry inventory; automatically null for asset-light and financial firms with no inventory line.